INIFY Laboratories AB becomes an independent company
STOCKHOLM – December 10, 2021 - ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10[th], it was resolved that the subsidiary INIFY Laboratories will become an independent company through a distribution of its shares to existing shareholders of ContextVision. The company will build an ultramodern pathology laboratory with a focus on high-quality diagnostics, initially for prostate cancer. Fredrik Palm is the CEO of the ContextVision group, including INIFY Laboratories. Palm will retain both